1. Home
  2. AUB vs ERAS Comparison

AUB vs ERAS Comparison

Compare AUB & ERAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Atlantic Union Bankshares Corporation

AUB

Atlantic Union Bankshares Corporation

HOLD

Current Price

$40.17

Market Cap

6.0B

Sector

Finance

ML Signal

HOLD

Logo Erasca Inc.

ERAS

Erasca Inc.

HOLD

Current Price

$14.91

Market Cap

6.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AUB
ERAS
Founded
1902
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.0B
6.3B
IPO Year
2005
2021

Fundamental Metrics

Financial Performance
Metric
AUB
ERAS
Price
$40.17
$14.91
Analyst Decision
Buy
Buy
Analyst Count
9
9
Target Price
★ $45.63
$24.11
AVG Volume (30 Days)
1.3M
★ 4.9M
Earning Date
10-20-2026
11-16-2026
Dividend Yield
★ 4.04%
N/A
EPS Growth
N/A
★ 36.23
EPS
★ 2.89
N/A
Revenue
N/A
N/A
Revenue This Year
$11.59
N/A
Revenue Next Year
$4.17
N/A
P/E Ratio
$20.32
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$30.87
$2.11
52 Week High
$43.62
$24.28

Technical Indicators

Market Signals
Indicator
AUB
ERAS
Relative Strength Index (RSI) 54.16 48.50
Support Level $36.47 $13.47
Resistance Level $43.20 $15.71
Average True Range (ATR) 0.87 1.02
MACD 0.19 0.05
Stochastic Oscillator 70.16 64.98

Price Performance

Historical Comparison
AUB
ERAS

About AUB Atlantic Union Bankshares Corporation

Atlantic Union Bankshares Corp is a financial and bank holding company based in the U.S. Through its community bank subsidiary and non-bank financial services affiliates, the company provides financial services, including banking, trust, and wealth management. It offers consumers and businesses a wide range of banking and related financial services, including checking, savings, certificates of deposit, and other depository services, as well as loans for commercial, industrial, residential mortgage, and consumer purposes. The company operates through two reportable operating segments: Wholesale Banking and Consumer Banking, with corporate support functions such as corporate treasury and others included in Corporate Other. It derives maximum revenue from the Wholesale Banking segment.

About ERAS Erasca Inc.

Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. Its focused RAS/MAPK pathway pipeline comprises modality-agnostic programs aligned with three therapeutic strategies of: targeting key upstream and downstream signaling nodes in the RAS/MAPK pathway; targeting RAS directly; and targeting escape routes that emerge in response to treatment. Its pipeline includes two clinical-stage programs (ERAS-0015, a pan-RAS molecular glue; and ERAS-4001, a pan-KRAS inhibitor), and ERAS-12, a discovery-stage program.

Share on Social Networks: